UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Selective Downregulation of the MDR1 Gene Product in Caco-2 Cells by Stable Transfection To Prove Its Relevance in Secretory Drug Transport

Molecular pharmaceutics, 2005-01, Vol.2 (1), p.64-73

2005

Volltextzugriff (PDF)

Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients

Chirality (New York, N.Y.), 2001, Vol.13 (3), p.130-134

2001

Volltextzugriff (PDF)

Radioligand-binding assay employing P-glycoprotein-overexpressing cells: testing drug affinities to the secretory intestinal multidrug transporter

Pharmaceutical research, 1998-07, Vol.15 (7), p.1001-1006

1998

Volltextzugriff (PDF)

Pregnancy-induced increase in metoprolol metabolism

Clinical pharmacology and therapeutics, 1985-06, Vol.37 (6), p.688-692

1985

Volltextzugriff (PDF)

Evidence for an interaction between the β-blocker pafenolol and bile salts in the intestinal lumen of the rat leading to dose-dependent oral absorption and double peaks in the plasma concentration : time profile

Pharmaceutical research, 1993-06, Vol.10 (6), p.879-883

1993

Volltextzugriff (PDF)

Pharmacokinetics of [ C] omeprazole in patients with impaired renal function

Clinical pharmacology and therapeutics, 1986-09, Vol.40 (3), p.344-351

1986

Volltextzugriff (PDF)

Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators

Therapeutic drug monitoring, 1990-07, Vol.12 (4), p.415-416

1990

Volltextzugriff (PDF)

Acute and Steady-State Pharmacokinetics and Antihypertensive Effects of Felodipine in Patients with Normal and Impaired Renal Function

Journal of clinical pharmacology, 1990-11, Vol.30 (11), p.1020-1030

1990

Volltextzugriff (PDF)

Pharmacokinetics of Felodipine in Chronic Hemodialysis Patients

Journal of clinical pharmacology, 1991-08, Vol.31 (8), p.709-713

1991

Volltextzugriff (PDF)

Pharmacokinetics of [14C]omeprazole in patients with liver cirrhosis

Clinical pharmacokinetics, 1993, Vol.24 (1), p.71-78

1993

Volltextzugriff (PDF)

Summary of Session I

Journal of clinical pharmacology, 1990-02, Vol.30 (S2), p.S55-S56

Regårdh, Carl -Gunnar

1990

Volltextzugriff (PDF)

Pharmacokinetic and Biopharmaceutic Aspects of Once Daily Treatment with Metoprolol CR/ZOK: A Review Article

Journal of clinical pharmacology, 1990-02, Vol.30 (S2), p.S2-S16

1990

Volltextzugriff (PDF)

Drug Biotransformation Interactions in Man V: Acetaminophen and Salicylic Acid

Journal of pharmaceutical sciences, 1971-04, Vol.60 (4), p.608-611

1971

Volltextzugriff (PDF)

The Relationship Between Metoprolol Plasma Concentration and Beta1-Blockade in Healthy Subjects: A Study on Conventional Metoprolol and Metoprolol CR/ZOK Formulations

Journal of clinical pharmacology, 1990-02, Vol.30 (S2), p.S46-S54

1990

Volltextzugriff (PDF)

Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay

The Journal of pharmacology and experimental therapeutics, 1999-01, Vol.288 (1), p.348

1999

Volltextzugriff (PDF)

Clinical pharmacokinetics of metoprolol

Clinical pharmacokinetics, 1980-01, Vol.5 (6), p.557-569

1980

Volltextzugriff (PDF)

Effect of Complex Formation on Drug Absorption XIV: Effect of N,N-Di-n-propylpropionamide on Intestinal Absorption of Certain Nonsteroid Drugs in the Rat

Journal of pharmaceutical sciences, 1972-03, Vol.61 (3), p.473-474

1972

Volltextzugriff (PDF)

Pharmacokinetics of Omeprazole and Metabolites Following Single Intravenous and Oral Doses of 40 and 80mg

Drug Investigation, 1990-12, Vol.2 (4), p.255-263

1990

Volltextzugriff (PDF)

Pharmacokinetics of Metoprolol Enantiomers after Administration of the Racemate and the S-Enantiomer as Oral Solutions and Extended Release Tablets

Drug Investigation, 1993-12, Vol.6 (6), p.320-329

1993

Volltextzugriff (PDF)

A survey of the pharmacological properties of metoprolol in animals and man

Acta pharmacologica et toxicologica, 1975-01, Vol.36 (Suppl 5), p.7-23

1975

Volltextzugriff (PDF)

Role of P-glycoprotein-mediated secretion in absorptive drug permeability : An approach using passive membrane permeability and affinity to P-glycoprotein

Journal of pharmaceutical sciences, 1999-10, Vol.88 (10), p.1067-1072

1999

Volltextzugriff (PDF)

Role of P‐glycoprotein‐mediated secretion in absorptive drug permeabiity: An approach using passive membrane permeability and affinity to P‐glycoprotein††Dedicated to Prof. B. C. Lippold on the occasion of his 60th birthday

Journal of pharmaceutical sciences, 1999-10, Vol.88 (10), p.1067-1072

1999

Volltextzugriff (PDF)

Dose-dependent intestinal absorption and significant intestinal excretion (exsorption) of the β-blocker pafenolol in the rat

Pharmaceutical research, 1993-05, Vol.10 (5), p.727-731

1993

Volltextzugriff (PDF)

Role of P‐glycoprotein‐mediated secretion in absorptive drug permeabiity: An approach using passive membrane permeability and affinity to P‐glycoprotein

Journal of pharmaceutical sciences, 1999-10, Vol.88 (10), p.1067-1072

1999

Volltextzugriff (PDF)

Kinetics of intravenous administered l-phenylalanine in patients with cirrhosis of the liver

Clinica chimica acta, 1977-08, Vol.78 (3), p.453-463

1977

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Selective Downregulation of the MDR1 Gene Product in Caco-2 Cells by Stable Transfection To Prove Its Relevance in Secretory Drug Transport

Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients

Radioligand-binding assay employing P-glycoprotein-overexpressing cells: testing drug affinities to the secretory intestinal multidrug transporter

Pregnancy-induced increase in metoprolol metabolism

Evidence for an interaction between the β-blocker pafenolol and bile salts in the intestinal lumen of the rat leading to dose-dependent oral absorption and double peaks in the plasma concentration : time profile

Pharmacokinetics of [ C] omeprazole in patients with impaired renal function

Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators

Acute and Steady-State Pharmacokinetics and Antihypertensive Effects of Felodipine in Patients with Normal and Impaired Renal Function

Pharmacokinetics of Felodipine in Chronic Hemodialysis Patients

Pharmacokinetics of [14C]omeprazole in patients with liver cirrhosis

Summary of Session I

Pharmacokinetic and Biopharmaceutic Aspects of Once Daily Treatment with Metoprolol CR/ZOK: A Review Article

Drug Biotransformation Interactions in Man V: Acetaminophen and Salicylic Acid

The Relationship Between Metoprolol Plasma Concentration and Beta1-Blockade in Healthy Subjects: A Study on Conventional Metoprolol and Metoprolol CR/ZOK Formulations

Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay

Clinical pharmacokinetics of metoprolol

Effect of Complex Formation on Drug Absorption XIV: Effect of N,N-Di-n-propylpropionamide on Intestinal Absorption of Certain Nonsteroid Drugs in the Rat

Pharmacokinetics of Omeprazole and Metabolites Following Single Intravenous and Oral Doses of 40 and 80mg

Pharmacokinetics of Metoprolol Enantiomers after Administration of the Racemate and the S-Enantiomer as Oral Solutions and Extended Release Tablets

A survey of the pharmacological properties of metoprolol in animals and man

Role of P-glycoprotein-mediated secretion in absorptive drug permeability : An approach using passive membrane permeability and affinity to P-glycoprotein

Role of P‐glycoprotein‐mediated secretion in absorptive drug permeabiity: An approach using passive membrane permeability and affinity to P‐glycoprotein††Dedicated to Prof. B. C. Lippold on the occasion of his 60th birthday

Dose-dependent intestinal absorption and significant intestinal excretion (exsorption) of the β-blocker pafenolol in the rat

Role of P‐glycoprotein‐mediated secretion in absorptive drug permeabiity: An approach using passive membrane permeability and affinity to P‐glycoprotein

Kinetics of intravenous administered l-phenylalanine in patients with cirrhosis of the liver

Suchergebnisse filtern